KOC
PRPH

Koss-Olinger Consulting’s ProPhase Labs PRPH Stock Holding History

Koss-Olinger Consulting’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,208
Closed -$184K – 334
2023
Q3 		$184K Buy
4,208
+1,692
+67% +$99.1K 0.03% 256
2023
Q2 		$183K Buy
2,516
+419
+20% +$34.1K 0.02% 263
2023
Q1 		$160K Buy
2,097
+114
+6% +$9.19K 0.02% 242
2022
Q4 		$191K Buy
+1,983
New +$214K 0.03% 219

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Koss-Olinger Consulting's PRPH Position: Q4 2023 in Review

Koss-Olinger Consulting sold out of ProPhase Labs (PRPH) in Q4 2023, closing a stake of 4,208 shares — an estimated $184K sold.

Koss-Olinger Consulting first reported a position in PRPH in Q4 2022 and held it in 4 quarters. The position peaked at $191K in Q4 2022. 27 funds tracked by Wall St. Rank hold PRPH as of Q4 2023.

  • Koss-Olinger Consulting reported no remaining ProPhase Labs position as of Q4 2023 after selling out during the quarter.
  • Koss-Olinger Consulting sold 4,208 ProPhase Labs shares in Q4 2023, an estimated $184K.
  • Koss-Olinger Consulting first reported a position in ProPhase Labs in Q4 2022 and held it in 4 quarters.
  • Koss-Olinger Consulting's ProPhase Labs position peaked at $191K in Q4 2022.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2023.

Based on Koss-Olinger Consulting's 13F filing for Q4 2023, filed 13 Feb 2024.